Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

Ruohoniemi David M.; Zhan Chenyang; Wei Jason; Kulkarni Kopal; Aaltonen Eric T.; Horn Jeremy C.; Hickey Ryan M.; Taslakian Bedros

首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

【24h】

Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

机译：钇-90玉米钇释放围绕免疫检查点抑制剂的安全性和有效性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To assess the safety and effectiveness of yttrium-90 radioembolization and checkpoint inhibitor immunotherapy within a short interval for the treatment of unresectable hepatic metastases.

机译：目的：评估短期内钇-90放射栓塞和检查点抑制剂免疫疗法治疗不可切除肝转移瘤的安全性和有效性。

著录项

来源
《Journal of vascular and interventional radiology: JVIR 》 |2020年第8期| 共9页
作者
Ruohoniemi David M.; Zhan Chenyang; Wei Jason; Kulkarni Kopal; Aaltonen Eric T.; Horn Jeremy C.; Hickey Ryan M.; Taslakian Bedros;
展开▼
作者单位

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

NYU Dept Radiol Div Intervent Radiol Sch Med 560 First Ave 2nd Floor New York NY 10016 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer [J] . Wen-Qian Li, Ling-Yu Li, Ri-Lan Bai, 中华医学杂志（英文版） . 2020 ,第021期
2. Comments on “Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999;112:430-432 [J] . 中华医学杂志（英文版） . 2001 ,第004期
3. Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma [J] . Zhan Chenyang, Ruohoniemi David, Shanbhogue Krishna P., Journal of vascular and interventional radiology: JVIR . 2020 ,第1期

机译：钇-90联合钇释放和免疫检查点抑制剂免疫治疗肝细胞癌的安全性
4. Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres [J] . Philipp M. Paprottka, Ralf-T. Hoffmann, Alexander Haug, CardioVascular and Interventional Radiology . 2012 ,第2期

机译：有症状的，无法切除的神经内分泌肝转移使用Yttrium-90微球的放射性栓塞。
5. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres [J] . PaprottkaP.M., HoffmannR.-T., HaugA., Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment . 2012 ,第2期

机译：使用钇90微球对有症状，无法切除的神经内分泌肝转移进行放射栓塞
6. ENGINEERING AND PRE-CLINICAL EVALUATION OF A HUMAN ENZYME IMMUNE CHECKPOINT INHIBITOR FOR CANCER THERAPY [C] . Everett Stone, John Blazek, Christos Karamitros, Enzyme Engineering Conference . 2018

机译：癌症治疗人酶免疫检查点抑制剂的工程与临床评价
7. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
8. Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review [O] . Michael Feretis, Andriy Solodkyy 2020

机译：Yttrium-90放射栓塞治疗无法切除的乳腺癌肝转移：系统评价
9. Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis [O] . Manlio Mencoboni, Marcello Ceppi, Marco Bruzzone, 2021

机译：现实世界晚期非小细胞肺癌患者免疫检查点抑制剂的有效性和安全性：审查与荟萃分析
10. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases

摘要

著录项

相似文献

相关主题

期刊订阅